BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29501316)

  • 1. Long term platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Chuang A; Del Valle Á; Cordova M
    Int J Pediatr Otorhinolaryngol; 2018 Apr; 107():75-79. PubMed ID: 29501316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Del Valle Á; Chuang A; Becker A
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
    Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
    Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
    Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
    Clemens E; Brooks B; de Vries ACH; van Grotel M; van den Heuvel-Eibrink MM; Carleton B
    PLoS One; 2019; 14(2):e0210646. PubMed ID: 30763334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A
    Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
    Dean JB; Hayashi SS; Albert CM; King AA; Karzon R; Hayashi RJ
    J Pediatr Hematol Oncol; 2008 Feb; 30(2):130-4. PubMed ID: 18376265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced hearing loss: the need for a long-term evaluating system.
    Yasui N; Adachi N; Kato M; Koh K; Asanuma S; Sakata H; Hanada R
    J Pediatr Hematol Oncol; 2014 May; 36(4):e241-5. PubMed ID: 24072246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
    Clemens E; de Vries AC; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; Pluijm SF; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; Neggers SJ; van Grotel M; M van den Heuvel-Eibrink M
    Pediatr Hematol Oncol; 2017 Mar; 34(2):120-129. PubMed ID: 28590156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of childhood hearing loss after in utero exposure to platinum agents.
    Finch LE; Cardonick EH
    Prenat Diagn; 2021 Oct; 41(11):1467-1474. PubMed ID: 34462927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
    Strebel S; Mader L; Sláma T; Waespe N; Weiss A; Parfitt R; Am Zehnhoff-Dinnesen A; Kompis M; von der Weid NX; Ansari M; Kuehni CE
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29755. PubMed ID: 35723448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
    Sriyapai T; Thongyai K; Phuakpet K; Vathana N; Buaboonnam J; Sanpakit K
    Turk J Pediatr; 2022; 64(3):531-541. PubMed ID: 35899566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
    Orgel E; Jain S; Ji L; Pollick L; Si S; Finlay J; Freyer DR
    Pediatr Blood Cancer; 2012 Jun; 58(6):953-8. PubMed ID: 21796767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.
    Yancey A; Harris MS; Egbelakin A; Gilbert J; Pisoni DB; Renbarger J
    Pediatr Blood Cancer; 2012 Jul; 59(1):144-8. PubMed ID: 22431292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
    Knight KR; Kraemer DF; Neuwelt EA
    J Clin Oncol; 2005 Dec; 23(34):8588-96. PubMed ID: 16314621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing loss in Mexican children treated with cisplatin.
    Castelán-Martínez OD; Jiménez-Méndez R; Rodríguez-Islas F; Fierro-Evans M; Vázquez-Gómez BE; Medina-Sansón A; Clark P; Carleton B; Ross C; Hildebrand C; Castañeda-Hernández G; Rivas-Ruiz R
    Int J Pediatr Otorhinolaryngol; 2014 Sep; 78(9):1456-60. PubMed ID: 25037447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term hearing degeneration after platinum-based chemotherapy in childhood.
    Einarsson EJ; Petersen H; Wiebe T; Fransson PA; Grenner J; Magnusson M; Moëll C
    Int J Audiol; 2010 Oct; 49(10):765-71. PubMed ID: 20874050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.